Soleno Therapeutics Inc

SLNO

Company Profile

  • Business description

    Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

  • Contact

    100 Marine Parkway
    Suite 400
    Redwood CityCA94065
    USA

    T: +1 650 213-8444

    E: [email protected]

    https://www.soleno.life

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    92

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,796.0023.70-0.27%
CAC 407,744.6431.26-0.40%
DAX 4023,764.51184.39-0.77%
Dow JONES (US)42,865.771.10-0.00%
FTSE 1008,874.289.930.11%
HKSE24,035.38331.56-1.36%
NASDAQ19,615.8899.11-0.50%
Nikkei 22538,173.09248.10-0.65%
NZX 50 Index12,649.1043.170.34%
S&P 5006,022.240.000.00%
S&P/ASX 2008,565.1027.00-0.31%
SSE Composite Index3,402.660.340.01%

Market Movers